ARKG did the selling. Plus the other trades that day and how ARK compares with the market.

Generated from ARK's own holdings data.
On 14 Oct 2026, ARK sold an estimated $14.3M of Personalis Inc (PSNL) across ARKG. No other trade that day was bigger.
Strip out the 0.7% that every holding moved as money came into the funds, and PSNL still shrank 21%. That excess is what we count as a trade.
This isn't a one-off. Across 6 trades in 30 days, ARK has sold a net $55.2M of the stock.
ARK made 12 real moves that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| PSNL Personalis IncSold 6 days running | ARKG | −$14.3M |
| CDNA Caredx IncSold 7 days running | ARKG | −$2.8M |
| NTLA Intellia Therapeutics Inc | ARKG and ARKK | −$2.3M |
| META Meta Platforms Inc | ARKF | +$2.0M |
| TER Teradyne Inc | ARKQ | −$1.3M |
| TOST Toast Inc | ARKF | −$1.2M |
Across the month, the money has gone mostly into Nvidia Corp ($81.0M), CoreWeave Inc ($53.9M), Veracyte Inc ($43.5M). Going the other way: Advanced Micro Devices ($136.4M), 10X Genomics Inc ($90.5M), Robinhood Markets Inc ($58.1M) have been cut.
This year ARKG is ahead of the market — +67.4% against +15.0% for the S&P 500.
Over the past year the gap is wider: ARKG returned +60.2% against +18.6% for the S&P 500, 42 points apart.
Over five years the gap is 125 points. ARKG is 57% below its all-time high from Jan 2021, having fallen as much as 84% at its worst in Apr 2025.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKG | +6.5% | +67.4% | +60.2% | -33.7% |
| S&P 500 (SPY) | +2.0% | +15.0% | +18.6% | +91.1% |
| Nasdaq-100 (QQQ) | +4.1% | +21.3% | +24.0% | +112.6% |
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.